Astrana Health Sees FY24 EPS $1.12-$1.36 Vs $1.42 Est.; Revenue $1.75B-$1.85B Vs $1.76B Est.
Portfolio Pulse from Benzinga Newsdesk
Astrana Health has updated its FY24 guidance, projecting EPS between $1.12 and $1.36, below the estimated $1.42. Revenue is expected to be between $1.75B and $1.85B, close to the estimated $1.76B. The company also provided guidance for net income and Adjusted EBITDA.
August 07, 2024 | 9:55 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Astrana Health's updated FY24 guidance shows lower-than-expected EPS but revenue in line with estimates. This could lead to short-term pressure on the stock price.
The lower-than-expected EPS guidance is likely to disappoint investors, potentially leading to a short-term decline in the stock price. However, the revenue guidance being in line with estimates may mitigate some of the negative impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100